long-term year benefici effect beta-adrenerg blockad bucindolol patient idiopath cardiomyopathi beta-adrenerg blockad promis therapeut approach cardiomyopathi bucindolol new beta-block favor effect short-term month trial idiopath cardiomyopathi long-term respons studi patient patient placebo group patient therapi long-term bucindolol therapi mean month mean patient age year median durat diseas month patient function class II class iii patient men end common follow-up time patient aliv bucindolol mean mg/day underw cardiac transplant left ventricular eject fraction baselin valu pair function class unchang exercis time versu min NS maxim oxygen uptak versu ml/kg min NS long-term bucindolol therapi substanti increas eject fraction function class stabl exercis perform 